Jeremy D. Hribar

1.2k total citations · 1 hit paper
24 papers, 975 citations indexed

About

Jeremy D. Hribar is a scholar working on Molecular Biology, Pharmacology and Pharmacology. According to data from OpenAlex, Jeremy D. Hribar has authored 24 papers receiving a total of 975 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pharmacology and 6 papers in Pharmacology. Recurrent topics in Jeremy D. Hribar's work include Pharmacogenetics and Drug Metabolism (9 papers), Ion Transport and Channel Regulation (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Jeremy D. Hribar is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Ion Transport and Channel Regulation (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). Jeremy D. Hribar collaborates with scholars based in United States, Switzerland and Canada. Jeremy D. Hribar's co-authors include Don C. DeJongh, Stephen Hanessian, Terence Radford, Glyn Dawson, Charles C. Sweeley, Aziz Karim, Chyung S. Cook, S. K. Paulson, Eduardo Hajdu and Loren Berry and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Nutrition and The Journal of Organic Chemistry.

In The Last Decade

Jeremy D. Hribar

24 papers receiving 900 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Analysis of trimethylsilyl derivatives of carbohydrates by gas chromatography and mass spectrometry

1969 345 citations Don C. DeJongh, Terence Radford et al. Journal of the American Chemical Society profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeremy D. Hribar United States	13	319	230	194	156	145	24	975
M. Kraml United States	18	396 1.2×	201 0.9×	115 0.6×	171 1.1×	77 0.5×	66	1.2k
Yorishige Imamura Japan	17	373 1.2×	106 0.5×	114 0.6×	155 1.0×	85 0.6×	121	900
Joseph Jarabak United States	23	584 1.8×	297 1.3×	265 1.4×	112 0.7×	111 0.8×	46	1.4k
Yoshihiko Shinohara Japan	18	245 0.8×	75 0.3×	188 1.0×	85 0.5×	57 0.4×	72	861
Jae B. Park United States	21	497 1.6×	185 0.8×	152 0.8×	108 0.7×	93 0.6×	57	1.6k
Alan P. Breau United States	16	207 0.6×	240 1.0×	37 0.2×	118 0.8×	87 0.6×	31	641
Cesar A. Lau‐Cam United States	17	292 0.9×	115 0.5×	51 0.3×	86 0.6×	113 0.8×	98	1.1k
H.E. Falke Netherlands	17	596 1.9×	73 0.3×	100 0.5×	305 2.0×	135 0.9×	33	1.4k
L. Vereczkey Hungary	21	341 1.1×	182 0.8×	66 0.3×	547 3.5×	106 0.7×	89	1.4k
Walter Meister Switzerland	13	380 1.2×	184 0.8×	65 0.3×	26 0.2×	134 0.9×	28	728

Countries citing papers authored by Jeremy D. Hribar

Since Specialization

Citations

This map shows the geographic impact of Jeremy D. Hribar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy D. Hribar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy D. Hribar more than expected).

Fields of papers citing papers by Jeremy D. Hribar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy D. Hribar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy D. Hribar. The network helps show where Jeremy D. Hribar may publish in the future.

Co-authorship network of co-authors of Jeremy D. Hribar

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy D. Hribar. A scholar is included among the top collaborators of Jeremy D. Hribar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy D. Hribar. Jeremy D. Hribar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cook, Chyung S., et al.. (2003). PHARMACOKINETICS AND METABOLISM OF [14C]EPLERENONE AFTER ORAL ADMINISTRATION TO HUMANS. Drug Metabolism and Disposition. 31(11). 1448–1455. 62 indexed citations

Cook, Chyung S., Loren Berry, David H. Kim, et al.. (2002). Involvement of CYP3A in the Metabolism of Eplerenone in Humans and Dogs: Differential Metabolism by CYP3A4 and CYP3A5. Drug Metabolism and Disposition. 30(12). 1344–1351. 47 indexed citations

Paulson, S. K., et al.. (2000). Comparison of celecoxib metabolism and excretion in mouse, rabbit, dog, cynomolgus monkey and rhesus monkey. Xenobiotica. 30(7). 731–744. 22 indexed citations

Paulson, Susan K., Ji Y. Zhang, Alan P. Breau, et al.. (2000). Pharmacokinetics, Tissue Distribution, Metabolism, and Excretion of Celecoxib in Rats. Drug Metabolism and Disposition. 28(5). 514–521. 118 indexed citations

Hribar, Jeremy D., et al.. (2000). Effect of diet and gavage on the dose- and dose-mode-dependent absorption and metabolism of bidisomide in rat. Xenobiotica. 30(5). 523–533. 1 indexed citations

Paulson, S. K., et al.. (2000). Metabolism and Excretion of [14C]Celecoxib in Healthy Male Volunteers. Drug Metabolism and Disposition. 28(3). 308–314. 121 indexed citations

Levin, Stuart, et al.. (1999). Lesions and Identification of Crystalline Precipitates of Glycoprotein IIb-IIIa Antagonists in the Rat Kidney. Toxicologic Pathology. 27(1). 38–43. 4 indexed citations

Yuan, Jun, David C.H. Yang, Jeremy D. Hribar, et al.. (1996). Isolation and identification of metabolites of leukotriene A4 hydrolase inhibitor SC-57461 in rats.. Drug Metabolism and Disposition. 24(10). 1124–1133. 9 indexed citations

Hribar, Jeremy D., et al.. (1995). Metabolism of a novel antiarrhythmic agent, bidisomide, in man: use of high resolution mass spectrometry to distinguish desisopropyl bidisomide from desacetyl bidisomide. Xenobiotica. 25(9). 981–991. 1 indexed citations

10.

Hribar, Jeremy D., et al.. (1992). Metabolism of actisomide in the dog, monkey and man: A novel rearrangement of N-dealkylated metabolites. European Journal of Drug Metabolism and Pharmacokinetics. 17(2). 145–154. 3 indexed citations

11.

Hribar, Jeremy D., et al.. (1990). Metabolism and pharmacokinetics of nufenoxole in animals and humans: an example of stereospecific hydroxylation of an isoquinuclidine ring. Xenobiotica. 20(10). 1065–1080. 3 indexed citations

12.

Burton, Earl G., Grant L. Schoenhard, R. Schmidt, et al.. (1989). Identification of N-β-L-Aspartyl-L-Phenylalanine as a Normal Constituent of Human Plasma and Urine. Journal of Nutrition. 119(5). 713–721. 4 indexed citations

13.

Cook, Chyung S., Grant L. Schoenhard, Charles E. Piper, et al.. (1988). Difference in metabolic profile of potassium canrenoate and spironolactone in the rat: Mutagenic metabolites unique to potassium canrenoate. Archives of Toxicology. 61(3). 201–212. 25 indexed citations

14.

Ruben, Zadok, et al.. (1985). The pH Dependence of Disobutamide-Induced Clear Cytoplasmic Vacuoles in Cultured Cells. Experimental Biology and Medicine. 180(1). 84–91. 6 indexed citations

15.

Karim, Aziz, et al.. (1977). Spironolactone: Diversity in Metabolic Pathways. Xenobiotica. 7(10). 585–600. 20 indexed citations

16.

Karim, Aziz, et al.. (1976). Spironolactone. I. Disposition and metabolism. Clinical Pharmacology & Therapeutics. 19(2). 158–169. 66 indexed citations

17.

Karim, Aziz, et al.. (1975). SPIRONOLACTONE METABOLISM IN MAN STUDIED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY. Drug Metabolism and Disposition. 3(6). 467–478. 30 indexed citations

18.

DeJongh, Don C., et al.. (1973). A mass spectral investigation of derivatives of kanamycin A. Tetrahedron. 29(18). 2707–2713. 12 indexed citations

19.

Brent, David A., Jeremy D. Hribar, & Don C. DeJongh. (1970). Pyrolysis of 2-pyrone, coumarin, and 2-pyridone. The Journal of Organic Chemistry. 35(1). 135–137. 21 indexed citations

20.

DeJongh, Don C., Terence Radford, Jeremy D. Hribar, et al.. (1969). Analysis of trimethylsilyl derivatives of carbohydrates by gas chromatography and mass spectrometry. Journal of the American Chemical Society. 91(7). 1728–1740. 345 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact